bioRxiv · 10.1101/426999
A novel rotifer-derived alkaloid paralyzes schistosome larvae and prevents infection
Abstract
Schistosomes are parasitic flatworms that infect over 200 million people, causing the neglected tropical disease, schistosomiasis. A single drug, praziquantel, is used to treat schistosome infection. Limitations in mass drug administration programs and the emergence of schistosomiasis in non-tropical areas indicate the need for new strategies to prevent infection. It has been known for several decades that rotifers colonizing the schistosomes snail intermediate host produce a water-soluble factor that paralyzes cercariae, the life-cycle stage infecting humans. In spite of its potential for preventing infection, the nature of this factor has remained obscure. Here, we report the purification and chemical characterization of Schistosome Paralysis Factor (SPF), a novel tetracyclic alkaloid produced by the rotifer Rotaria rotatoria. We show that this compound paralyzes schistosome cercariae and prevents infection, and does so more effectively than analogous compounds. This molecule provides new directions for understanding cercariae motility and new strategies for preventing schistosome infection.
Source connections
Explore related subjects
Keep this discovery
Gao, J., Yang, N., Lewis, F. A., Yau, P., Collins, J. J., Sweedler, J. V., Newmark, P. A.. 2018-09-27. A novel rotifer-derived alkaloid paralyzes schistosome larvae and prevents infection. https://doi.org/10.1101/426999
Cite the original work for its findings. Save a collection to share your selection of sources.